Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Colorcon Inc. and Applied DNA signed a supply agreement granting Colorcon exclusive right to use Applied DNA’s SigNature molecular tags in film coatings for solid oral dosage forms, and non-exclusive rights to use it in inks and colorants for SOD pharmaceuticals.

Colorcon and Applied DNA to Join Forces in Taggants for Pharmaceutical Traceability

The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.

Reig Jofre and Leanbio Form Joint Venture to Develop Biosimilars

The European approval marks the first approval for a biosimilar in that region resulting from the companies’ joint portfolio.

Mylan and Biocon Get Approvals for Biosimilar Insulin Glargine in Europe and Australia

Fujifilm acquires cell culture media companies Irvine Scientific Sales Company and IS Japan.

Fujifilm Expands Bioprocessing Scope

The active pharmaceutical ingredient and excipient provider has expanded its parenteral ingredient manufacturing capacity and lab services.

BioSpectra Expands Manufacturing Capacity and Lab Services

A new scientific publication examines analytical processes for the emerging legal cannabis industry.

Publication Brings Analytical Science to Cannabis Industry

The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.

FDA Grants Priority Review to AstraZeneca’s Leukemia Biologic

Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics. 

Pfizer Transfers CAR-T Assets to Allogene

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Particle engineering using jet milling or spray drying can be used to obtain appropriate particle characteristics for inhalation drug products.

Optimizing Particle Engineering Methods for Inhalation Drug Products

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Access to multiple analytical techniques is essential for fully characterizing complex protein formulations.